T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
UnitedHealth
UNH
|
$865M |
| 2 |
AbbVie
ABBV
|
$688M |
| 3 |
Intuit
INTU
|
$574M |
| 4 |
Xcel Energy
XEL
|
$466M |
| 5 |
Exelon
EXC
|
$432M |
Top Sells
| 1 |
GE Aerospace
GE
|
$974M |
| 2 |
TE Connectivity
TEL
|
$629M |
| 3 |
Equifax
EFX
|
$338M |
| 4 |
KLA
KLAC
|
$321M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$299M |
Sector Composition
| 1 | Technology | 24.86% |
| 2 | Healthcare | 22.76% |
| 3 | Financials | 12.37% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 11.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Lantheus
LNTH
$3.73B
| $88.5M | 0.06% |
1,071,578
+12,013
| +1% | +$992K |
|
277
Mobileye
MBLY
$11.1B
| $88.3M | 0.06% |
2,040,057
-161,950
| -7% | -$7.01M |
|
|
ABCM
278
DELISTED
Abcam plc American Depositary Shares
ABCM
| $88.2M | 0.06% |
6,556,002
+465,616
| +8% | +$6.27M |
|
279
Orion
OEC
$569M
| $87.2M | 0.06% |
3,340,741
-304,252
| -8% | -$7.94M |
|
280
Phreesia
PHR
$1.81B
| $87.1M | 0.06% |
2,696,121
+19,242
| +0.7% | +$621K |
|
281
BlackLine
BL
$3.26B
| $86.1M | 0.06% |
1,281,913
-14,393
| -1% | -$966K |
|
282
Western Alliance Bancorporation
WAL
$9.87B
| $86M | 0.06% |
2,419,200
-3,639,043
| -60% | -$129M |
|
283
Markel Group
MKL
$24.6B
| $85.8M | 0.06% |
+67,165
| New | +$85.8M |
|
284
Mueller Water Products
MWA
$4.06B
| $85.7M | 0.06% |
6,150,927
+339,548
| +6% | +$4.73M |
|
285
US Physical Therapy
USPH
$1.26B
| $85.6M | 0.06% |
874,570
-41,261
| -5% | -$4.04M |
|
286
NeoGenomics
NEO
$1.06B
| $85.3M | 0.06% |
4,901,440
+1,984,505
| +68% | +$34.6M |
|
287
Dorman Products
DORM
$4.84B
| $85.1M | 0.06% |
986,389
+10,515
| +1% | +$907K |
|
288
Republic Services
RSG
$72.5B
| $84.9M | 0.06% |
+627,517
| New | +$84.9M |
|
289
Agilysys
AGYS
$2.98B
| $84.1M | 0.06% |
1,018,738
+89,265
| +10% | +$7.37M |
|
290
Caesars Entertainment
CZR
$5.19B
| $83.8M | 0.06% |
+1,717,030
| New | +$83.8M |
|
291
Virtus Investment Partners
VRTS
$1.29B
| $83.1M | 0.06% |
436,593
+3,211
| +0.7% | +$611K |
|
|
SRCL
292
DELISTED
Stericycle Inc
SRCL
| $82.6M | 0.06% |
1,893,735
-842,479
| -31% | -$36.7M |
|
|
BFS
293
Saul Centers
BFS
$816M
| $82.4M | 0.06% |
2,113,977
-1,647
| -0.1% | -$64.2K |
|
294
McGrath RentCorp
MGRC
$2.98B
| $82M | 0.06% |
878,505
+66,890
| +8% | +$6.24M |
|
295
Toast
TOST
$24.9B
| $81.8M | 0.06% |
4,607,591
-2,976,328
| -39% | -$52.8M |
|
296
Certara
CERT
$1.68B
| $79.7M | 0.06% |
3,304,129
+1,605,636
| +95% | +$38.7M |
|
297
Rivian
RIVN
$17.5B
| $78.6M | 0.06% |
5,079,742
-4,616,923
| -48% | -$71.5M |
|
|
XIFR
298
XPLR Infrastructure, LP
XIFR
$977M
| $78.3M | 0.06% |
1,288,965
-502,301
| -28% | -$30.5M |
|
|
NEX
299
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $77.5M | 0.06% |
9,751,976
-469,862
| -5% | -$3.74M |
|
300
Procept Biorobotics
PRCT
$2.1B
| $77.4M | 0.06% |
2,725,289
+27,404
| +1% | +$778K |
|